Stocks in Action USA: Kura Oncology, Carnival, Netflix
Reading Time: 4 minutes
Kura Oncology (KURA) – The biotech specialist makes waves with cancer data – early study successes drive stock up double digits! The stock of Kura Oncology is reacting with strong price gains to promising study data in the field of cancer research. The trigger is the first results of an ongoing study for the treatment of advanced renal cancer (clear cell renal cell carcinoma). According to company information, the tested combination therapy shows an objective response rate of 44% as well as a disease control rate of 94%. Additionally, tumor...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
